FDA Adverse Event Death Summary report: N

GORE-TEX CARDIOVASCULAR PATCH

MDR report key: 11689105 · Received April 19, 2021

Report

Report Number
3007284313-2021-01396
Event Type
Death
Date Received
April 19, 2021
Date of Event
December 1, 2006
Report Date
April 19, 2021
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
DXZ
PMA / PMN Number
K811841
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE ARTICLE CITATION: VALVED PATCH FOR VENTRICULAR SEPTAL DEFECT WITH PULMONARY ARTERIAL HYPERTENSION. ABBAS AFRASIABI, MAHMOUD SAMADI, HOSSEIN MONTAZERGAEM, PUBLISHED IN ASIAN CARDIOVASCULAR AND THORACIC ANNALS, 2006 DEC; 14(6):501-4. AS THE DATE OF EVENT IS UNKNOWN, THE EVENT DATE USED WILL BE DECEMBER 1, 2006, AS THE ARTICLE WAS PUBLISHED DECEMBER 2006. THE GORE-TEX® CARDIOVASCULAR PATCH INSTRUCTIONS FOR USE STATES: USE OF THIS PRODUCT IN APPLICATIONS OTHER THAN THOSE INDICATED HAS THE POTENTIAL FOR SERIOUS COMPLICATIONS.

Description of Event or Problem · 1

THIS INFORMATION WAS RECEIVED THROUGH LITERATURE ARTICLE "VALVED PATCH FOR VENTRICULAR SEPTAL DEFECT WITH PULMONARY ARTERIAL HYPERTENSION" ABBAS AFRASIABI, MAHMOUD SAMADI, HOSSEIN MONTAZERGAEM, PUBLISHED IN ASIAN CARDIOVASCULAR AND THORACIC ANNALS, 2006 DEC; 14(6):501-4. THE ARTICLES OBJECTIVE/AIM IS TO REPORT OUR EXPERIENCE OF CLOSURE OF A LARGE VENTRICULAR SEPTAL DEFECT (VSD) IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION, USING A VALVED PATCH. THE ARTICLE REPORTS FROM MARCH 1998 TO DECEMBER 2004, 16 ACYANOTIC PATIENTS AGED 2 TO 22 YEARS (MEAN, 7 ± 5.7 YEARS) WITH A LARGE VENTRICULAR SEPTAL DEFECT AND ELEVATED PULMONARY VASCULAR RESISTANCE (9.6 ± 3.8 WOOD UNITS) UNDERWENT SURGERY. A GORE-TEX PATCH WITH A 5¿8 MM LONGITUDINAL SLIT IN THE CENTER WAS USED. A PIECE OF PERICARDIUM WAS SEWN AROUND THE SLIT ON ONE SIDE OF THE PATCH, EXCEPT FOR THE UPPER QUARTER. IN ALL PATIENTS, THE DEFECT WAS CLOSED WITH A TRIMMED PATCH AND THE PERICARDIAL ASPECT WAS PLACED ON THE LEFT VENTRICULAR SIDE TO ALLOW RIGHT-TO-LEFT SHUNTING. ONE PATIENT DIED ON POSTOPERATIVE DAY 5 DUE TO PERSISTENT SEVERE PULMONARY ARTERIAL HYPERTENSION, A RIGHT-TO-LEFT SHUNT VIA THE VALVED PATCH, AND LOW SYSTEMIC OXYGEN SATURATION. THE ARTICLE INDICATES THIS IS AN OFF LABEL USE OF THE GORE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
587416 GORE-TEX CARDIOVASCULAR PATCH PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE DXZ W. L. GORE & ASSOCIATES, INC.

Patients

Seq Age Sex Outcome Treatment
1 4 YR Death